MENU

CMMB Chemomab Therapeutics Ltd Forecast, Technical & Fundamental Analysis

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs... Show more

Industry: #Biotechnology
CMMB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
CMMB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CMMB is expected to report earnings to fall 100.00% to 0 cents per share on November 06

Chemomab Therapeutics Ltd CMMB Stock Earnings Reports
Q3'26
Est.
$0.00
Q2'26
Est.
$0.00
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.23
Q3'25
Missed
by $0.31
The last earnings report on August 19 showed earnings per share of 0 cents, missing the estimate of 0 cents. With 78.95K shares outstanding, the current market capitalization sits at 12.02M.
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical services

Industry Biotechnology

Industry
Biotechnology
Address
10 Habarzel Street
Phone
+972 773310156
Employees
10
Web
https://www.chemomab.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EWTX40.601.41
+3.60%
Edgewise Therapeutics
HCACU10.32N/A
N/A
Hall Chadwick Acquisition Corp
XYZ73.53-0.52
-0.70%
Block Inc
KPRX2.56-0.04
-1.54%
Kiora Pharmaceuticals Inc.
WHG18.63-0.37
-1.95%
Westwood Holdings Group

CMMB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with CANF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
-26.09%
CANF - CMMB
45%
Loosely correlated
+0.92%
AXON - CMMB
37%
Loosely correlated
+0.70%
SPRB - CMMB
36%
Loosely correlated
+2.77%
CRSP - CMMB
33%
Loosely correlated
-1.21%
IDYA - CMMB
33%
Poorly correlated
+1.48%
More
Chemomab Therapeutics (CMMB) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com